Coronavirus SARS-CoV2: BESSY II data accelerate drug development

Schematic representation of the coronavirus protease. The enzyme comes as a dimer consisting of two identical molecules. A part of the dimer is shown in colour (green and purple), the other in grey. The small molecule in yellow binds to the active centre of the protease and could be used as blueprint for an inhibitor.

Schematic representation of the coronavirus protease. The enzyme comes as a dimer consisting of two identical molecules. A part of the dimer is shown in colour (green and purple), the other in grey. The small molecule in yellow binds to the active centre of the protease and could be used as blueprint for an inhibitor. © H. Tabermann/HZB

Filmclip: At BESSY II, the main protease of SARS-CoV2 has been decoded. This might help to develop drugs. © HG Medien/HZB

01:11

A coronavirus is keeping the world in suspense. SARS-CoV-2 is highly infectious and can cause severe pneumonia with respiratory distress (COVID-19). Scientists are doing research in order to prevent the viruses from multiplying. A team from the University of Lübeck and from Helmholtz Centre for Infection Research (HZI) has now found a promising approach. Using the high-intensity X-ray light from the Berlin synchrotron source BESSY II, they have decoded the three-dimensional architecture of the main protease of SARS-CoV-2. This protein is involved in the reproduction of the virus. Analysing its 3D architecture allows the systematic development of drugs which inhibit the reproduction of the virus.

Teams around the world are working hard to develop active substances against SARS-CoV-2. The structural analysis of functional proteins of the virus is very helpful for this goal. The function of a protein is closely related to its 3D architecture. If this 3D architecture is known, it is possible to identify specific points of attack for active substances.

Inhibiting the reproduction

A special protein is involved in the reproduction of the virus: the viral main protease (Mpro or also 3CLpro). A team led by Prof. Dr. Rolf Hilgenfeld, University of Lübeck, has now decoded the 3D architecture of the main protease of SARS-CoV-2. The researchers have used the high-intensity X-ray light from the BESSY II facility of the Helmholtz-Zentrum Berlin.

Fast track at BESSY II

"For such issues of highest relevance, we can offer fast track access to our instruments", says Dr. Manfred Weiss, who heads the Research Group Macromolecular Crystallography (MX) at HZB. At the so-called MX instruments tiny protein crystals can be analysed with highly brilliant X-ray light. The images contain information about the 3D architecture of the protein molecules. The complex shape of the protein molecule and its electron density is then calculated by computer algorithms.

Targets for active substances

The 3D architecture provides concrete starting points for developing active substances or inhibitors. These drugs could dock specifically to target points of the macromolecule and impede its function. Rolf Hilgenfeld is a world-renowned expert in the field of virology and already developed an inhibitor against the SARS-virus during the 2002/2003 SARS pandemic. In 2016, he succeeded in deciphering an enzyme of the Zika virus. 

 

Science, 20. March 2020: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Linlin Zhang, Daizong Lin, Xinyuanyuan Sun, Ute Curth, Christian Drosten, Lucie Sauerhering, Stephan Becker, Katharina Rox, Rolf Hilgenfeld

DOI: 10.1126/science.abb3405 

arö

You might also be interested in

  • Perovskite solar cells from the slot die coater - a step towards industrial production
    Science Highlight
    16.03.2023
    Perovskite solar cells from the slot die coater - a step towards industrial production
    Solar cells made from metal halide perovskites achieve high efficiencies and their production from liquid inks requires only a small amount of energy. A team led by Prof. Dr. Eva Unger at Helmholtz-Zentrum Berlin is investigating the production process. At the X-ray source BESSY II, the group has analyzed the optimal composition of precursor inks for the production of high-quality FAPbI3 perovskite thin films by slot-die coating. The solar cells produced with these inks were tested under real life conditions in the field for a year and scaled up to mini-module size.
  • Superstore MXene: New proton hydration structure determined
    Science Highlight
    13.03.2023
    Superstore MXene: New proton hydration structure determined
    MXenes are able to store large amounts of electrical energy like batteries and to charge and discharge rather quickly like a supercapacitor. They combine both talents and thus are a very interesting class of materials for energy storage. The material is structured like a kind of puff pastry, with the MXene layers separated by thin water films. A team at HZB has now investigated how protons migrate in the water films confined between the layers of the material and enable charge transport. Their results have been published in the renowned journal Nature Communications and may accelerate the optimisation of these kinds of energy storage materials.
  • TU Berlin appoints Renske van der Veen as professor
    News
    22.02.2023
    TU Berlin appoints Renske van der Veen as professor
    For the past two years, Dr Renske van der Veen has led a research group in time-resolved X-ray spectroscopy and electron microscopy at HZB. Her research focuses on catalytic processes that enable, for example, the production of green hydrogen. She has now been appointed to a S-W2 professorship at the Institute of Optics and Atomic Physics (IOAP) at the Technische Universität Berlin.